心房颤动合并冠状动脉支架置入患者的三联抗栓治疗 - Suppr

Suppr

超能文献

Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.

作者信息

Paikin Jeremy S, Wright Douglas S, Crowther Mark A, Mehta Shamir R, Eikelboom John W

机构信息

McMaster University, Hamilton, Ontario, Canada.

出版信息

Circulation. 2010 May 11;121(18):2067-70. doi: 10.1161/CIRCULATIONAHA.109.924944.

DOI:10.1161/CIRCULATIONAHA.109.924944

PMID:20458022

Abstract

摘要

相似文献

Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.

Circulation. 2010 May 11;121(18):2067-70. doi: 10.1161/CIRCULATIONAHA.109.924944.

"Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.

J Am Coll Cardiol. 2008 Feb 26;51(8):826-7. doi: 10.1016/j.jacc.2007.11.034.

Antithrombotic therapy during and after percutaneous coronary intervention in patients with atrial fibrillation.

Circulation. 2013 Oct 29;128(18):2058-61. doi: 10.1161/CIRCULATIONAHA.113.002250.

[Expert answer. Coronary artery patients with atrial fibrillation on anticoagulation treatment may need antithrombotic treatment. What kind is there?].

Turk Kardiyol Dern Ars. 2012 Jun;40(4):395.

Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting.

QJM. 2008 Sep;101(9):749-51. doi: 10.1093/qjmed/hcn082. Epub 2008 Jul 29.

[Antithrombotic strategies for patients with atrial fibrillation and coronary artery disease].

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 May;42(5):372-3.

Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.

Am J Cardiol. 2009 Nov 1;104(9):1171-8. doi: 10.1016/j.amjcard.2009.06.027.

Atrial fibrillation and coronary artery disease: which antithrombotic treatment strategy?

Curr Opin Cardiol. 2014 Nov;29(6):595-600. doi: 10.1097/HCO.0000000000000106.

Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):673-80. doi: 10.1038/ncpcardio0712.

Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence.

Europace. 2009 Jul;11(7):842-3. doi: 10.1093/europace/eup161.

引用本文的文献

Direct oral anticoagulant and antiplatelet therapy for extracranial neurovascular stenting in patients with atrial fibrillation.

BMC Neurol. 2025 May 24;25(1):218. doi: 10.1186/s12883-025-04240-2.

Oral anticoagulant (OAC) monotherapy vs. dual-antithrombotic therapy (DAT) in patients with atrial fibrillation and coronary artery disease; a meta-analysis of four randomized controlled trials.

Ann Med Surg (Lond). 2024 Dec 12;87(2):791-799. doi: 10.1097/MS9.0000000000002957. eCollection 2025 Feb.

Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.

Theranostics. 2024 May 19;14(8):3267-3281. doi: 10.7150/thno.97517. eCollection 2024.

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy.

J Thromb Thrombolysis. 2023 May;55(4):667-679. doi: 10.1007/s11239-023-02784-z. Epub 2023 Mar 11.

Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study.

Thromb J. 2021 Dec 14;19(1):100. doi: 10.1186/s12959-021-00353-z.

Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.

Circulation. 2021 Oct 12;144(15):1196-1211. doi: 10.1161/CIRCULATIONAHA.121.056680. Epub 2021 Aug 29.

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.

J Lipid Atheroscler. 2019 May;8(1):8-14. doi: 10.12997/jla.2019.8.1.8. Epub 2019 May 10.

Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials.

J Clin Med. 2020 Apr 8;9(4):1062. doi: 10.3390/jcm9041062.

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting.

Res Pract Thromb Haemost. 2020 Mar 9;4(3):357-365. doi: 10.1002/rth2.12319. eCollection 2020 Mar.

Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis.

Cochrane Database Syst Rev. 2019 Dec 19;12(12):CD013252. doi: 10.1002/14651858.CD013252.pub2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验